FLASCO OncoPod

Join Dr. Rami Komrokji of Moffitt Cancer Center as he shares expert insights on current trends and considerations in the management of Myelodysplastic Syndromes (MDS).

Tune in as Dr. Tiago Biachi, MD, from Moffitt Cancer Center, explores the latest advancements in immunotherapy for gastroesophageal cancer. In this episode, he breaks down key clinical trial data, examines emerging treatment strategies, and discusses the evolving role of immunotherapy in improving patient outcomes. Don’t miss this expert insight into the future of cancer care!

Tune in for Part 2 of Updates in IDHm Gliomas with FLASCO Neuro-Oncology Captain, Ashley Ghiaseddin, MD, FAAN. This informative podcast covers current and emerging treatments, the evolving role of IDH inhibitors, and the key challenges in treatment, including resistance and tumor heterogeneity. Whether you’re a clinician, researcher, or oncology professional, this FLASCO OncoPod provides valuable...

Join FLASCO for Part I of Updates in IDHm Gliomas with FLASCO Neuro-Oncology Captain, Ashley Ghiaseddin, MD, FAAN. This informative podcast covers current and emerging treatments, the evolving role of IDH inhibitors, and the key challenges in treatment, including resistance and tumor heterogeneity. Whether you’re a clinician, researcher, or oncology professional, this FLASCO OncoPod provides valua...

In this installment of the FLASCO OncoPod , we explore the critical role of Minimal Residual Disease (MRD) testing in advancing cancer care with Dr. Ivan Borrello , a distinguished oncologist from Tampa General Hospital . Dr. Borrello dives into the science behind MRD testing, its applications in hematologic malignancies, and how it informs treatment decisions and long-term patient outcomes. Gain...

In this episode of the FLASCO OncoPod , we are joined by renowned oncologist Dr. Edgardo Santos , MD, FACP, FCCP, FASCO, from The Oncology Institute of Hope and Innovation (TOI) to discuss the latest updates in lung cancer care. Dr. Santos shares insights into groundbreaking research, advancements in treatment protocols, and the evolving landscape of lung cancer management. From targeted therapies...

In this episode of the FLASCO OncoPod , we delve into the Management and Treatment of Polycythemia Vera (PV) with expert insights from Dr. Andrew Kuykendall , a leading hematologist from Moffitt Cancer Center . Join us as Dr. Kuykendall explores the latest advancements in PV care, including symptom management, therapeutic strategies, and emerging research that is shaping the future of treatment. W...

Introducing the first-ever FLASCO OncoPod! Join FLASCO President, Dr. Maen Hussein , as he dives into the critical role state oncology societies play in advancing cancer care. In this inaugural episode, Dr. Hussein discusses the importance of becoming an active member of your state society, sharing how FLASCO stands as a dedicated supporter and advocate for oncology professionals across Florida. F...